Table 2.
Renal function at every follow-up time point (n=25)
| Measurement | Follow-Up | Renal Function | Good Outcome (n=5) | Poor Outcome (n=20) | P Value |
|---|---|---|---|---|---|
| Serum creatinine (μmol/L) | At biopsy | 252.0 (103.0–825.0) | 191.0 (160.0–295.0) | 268.5 (103.0–825.0) | 0.03 |
| 1 wk | 193.5 (117.0–825.0) | 151.0 (118.0–206.0) | 195.5 (117.0–825.0) | 0.07 | |
| 2 wk | 164.5 (111.0–469.0) | 117.0 (114.0–171.0) | 164.8 (111.0–469.0) | 0.15 | |
| 1 mo | 120.0 (98.0–206.0) | 102.0 (100.0–103.5) | 121.5 (98.0–206.0) | 0.01 | |
| 3 mo | 110.0 (73.6–185.0) | 97.0 (95.0–125.0) | 110.3 (73.6–185.0) | 0.41 | |
| 6 mo | 112.0 (81.2–154.0) | 88.0 (81.2–92.0) | 113.0 (92.0–154.0) | 0.002 | |
| 12 mo | 108.0 (73.0–177.0) | 86.0 (73.0–102.0) | 112.0 (95.0–177.0) | 0.001 | |
| Estimated GFR (ml/min per 1.73 m2) | At biopsy | 17.7 (5.7–46.1) | 31.9 (15.4–38.0) | 17.1 (5.7–46.1) | 0.04 |
| 1 wk | 26.5 (5.8–52.9) | 45.4 (23.8–52.9) | 25.1 (5.8–41.8) | 0.02 | |
| 2 wk | 31.7 (11.4–55.2) | 50.9 (33.8–55.2) | 30.6 (11.4–50.2) | 0.02 | |
| 1 mo | 44.6 (24.6–95.2) | 62.0 (57.0–63.1) | 43.8 (24.6–95.2) | 0.02 | |
| 3 mo | 49.3 (28.2–104.0) | 60.6 (49.3–67.1) | 48.9 (28.2–104.0) | 0.19 | |
| 6 mo | 50.1 (32.4–83.1) | 71.5 (66.5–83.1) | 47.3 (32.4–81.0) | 0.01 | |
| 12 mo | 52.0 (29.4–92.4) | 80.5 (66.6–92.4) | 49.4 (29.4–59.3) | <0.001 |